BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Beach

  Mirum Pharmaceuticals Secures $120 Million in Series A Financing to Develop Phase 3-Ready Maralixibat for Rare Liver Diseases

  Maralixibat Phase 2b study interim analysis suggests proof of concept in Alagille syndrome

  November 7, 2018

   · 

  6 min read
• Business

  Compugen Reports Third Quarter 2018 Results

  Compugen Ltd. today reported financial results for the third quarter ended September 30, 2018.

  November 7, 2018

   · 

  8 min read
• Business

  Sierra Oncology to Present at the Jefferies 2018 London Healthcare Conference

  “Targeted Therapeutics for Hematology & Oncology” scheduled for 5:20 p.m. GMT on November 14, 2018

  November 7, 2018

   · 

  3 min read
• Alpha Tau Medical Launches New Clinical Trials in Italy with Leading Cancer Centers, La Sapienza and IFO

  Trials will investigate the efficacy of its breakthrough cancer treatment, Alpha DaRT, in Squamous Cell Carcinoma (SCC) of the Skin, and Cutaneous and Mucosal malignant Neoplasia (CMN)

  November 7, 2018

   · 

  2 min read
• Drug Development

  Acceleron Announces Preclinical Presentations on Sotatercept in Pulmonary Arterial Hypertension at the 2018 American Heart Association Scientific Session

  Acceleron Pharma Inc. today announced plans to deliver three preclinical presentations on sotatercept in Pulmonary Arterial Hypertension (PAH) at the 2018 American Heart Association (AHA) Scientific Session in Chicago, IL, November 10-12, 2018.

  November 7, 2018

   · 

  6 min read
• Business

  Rocket Pharmaceuticals Reports Third Quarter 2018 Financial Results and Operational Highlights

  Fanconi Anemia (FA) Data Presented at ESGCT Shows Increasing and Durable Engraftment for up to 30 Months with First Generation Product

  November 7, 2018

   · 

  10 min read
• BioMidwest

  Exicure Announces November 2018 Investor and Scientific Conference Schedule

  Exicure, Inc. announced today plans to attend two investor conferences and two scientific conferences in November 2018.

  November 7, 2018

   · 

  3 min read
• Business

  PROCEPT BioRobotics Appoints Kevin Waters as Chief Financial Officer

  PROCEPT BioRobotics today announced the appointment of Kevin Waters as chief financial officer.

  November 7, 2018

   · 

  2 min read
• BioMidwest

  Aerpio Reports Third Quarter 2018 Financial Results and Provides Business Update

  TIME-2b Clinical Trial of AKB-9778 in Patients with Diabetic Retinopathy On Track

  November 7, 2018

   · 

  8 min read
• BioMidwest

  Kraig Biocraft Laboratories Begins Scale up of Second Generation Dragon Silk

  Kraig Biocraft Laboratories, Inc. announces today that it has begun the scale up of its recently announced second generation Dragon Silk.

  November 7, 2018

   · 

  3 min read